David Hollander - Insider Trading & Ownership

Entity
Individual
Location
C/O Aerie Pharmaceuticals, Inc., 4301 Emperor Blvd., Suite 400, Durham, NC
Summary
The estimated net worth of David Hollander is at least $907K dollars as of November 19, 2024. David Hollander is the Chief R&D Officer of AERIE PHARMACEUTICALS INC and owns shares of AERIE PHARMACEUTICALS INC stock worth about $469K. David Hollander is the CMO & Global Therapeutics Lead of Revance Therapeutics, Inc. and owns shares of Revance Therapeutics, Inc. (RVNC) stock worth about $438K.
All Insider Reports
All Insider Reports

Ownership of David Hollander

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AERI AERIE PHARMACEUTICALS INC Chief R&D Officer $469K Feb 4, 2022
RVNC Revance Therapeutics, Inc. CMO & Global Therapeutics Lead $438K -$16.3K -3.59% Nov 18, 2024
KPRX, KPHMW KIORA PHARMACEUTICALS INC Director Jul 1, 2024

Insider Transactions Reported by David Hollander:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.